Changes in phospholipase D activity of leukocytes during human systemic inflammatory response syndrome induced by cardiopulmonary bypass

被引:0
|
作者
Wu, M
Lu, YB [1 ]
Chen, RK
Zhou, HL
机构
[1] Zhejiang Univ, Sch Med, Dept Pharmacol, Hangzhou 310031, Peoples R China
[2] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Cardiovasc Thorac Surg, Hangzhou 310009, Peoples R China
关键词
phospholipase D; leukocytes; systemic inflammatory response syndrome; cardiopulmonary bypass;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To investigate the fluctuations in arterial leukocyte phospholipase D (PLD) activity during the perioperative period of open heart surgery under cardiopulmonary bypass (CPB), and the relationship between PLD activity and systemic inflammatory response induced by CPB. Methods Arterial blood was obtained from 26 patients undergoing open heart surgery at 8 different time points during the perioperative period, from which leukocytes were isolated for determination of PLD activity, CD11b expression and myeloperoxidase (MPO) activity. Plasma IL-6, IL-8 and C-reactive protein were also determined. The 26 cases were retrospectively divided into 3 groups according to perfusion time in order to detect the possible influences of CPB on PLD activity and IL-6 and IL-8 levels. Results When the ascending aorta was declamped, average arterial leukocyte PLD activity was 0.305 +/- 0.132 nmol choline . min(-1) . mg(-1), 5.0 times higher of the pre-CPB value, and remained (5.4 times higher of the pre-CPB level) at 72 hours after CPB. Leukocyte CD11b expression and plasma IL-6 and IL-8 levels increased significantly at the end of CPB, while MPO activity and C-reactive protein concentration reached their peaks at 1 and 24 hours, respectively, after CPB. At the end of CPB, the arterial leukocyte PLD activity of patients whose CPB duration was longer than 90 minutes were 1.82- and 1.74-fold that of the other two groups with CPB lasting between 90 and 60 minutes and less than 60 minutes. Conclusions Arterial leukocyte PLD activity rises significantly in CPB and its elevation is earlier and more persistent than other inflammation-related indicators tested; longer CPB duration leads to higher leukocyte PLD activity at the end of CPB. These results imply that PLD could be a new target for prevention of systemic inflammatory response induced by CPB.
引用
收藏
页码:873 / 877
页数:5
相关论文
共 50 条
  • [1] Effects of methylprednisolone and aprotinin on phospholipase D activity of leukocytes in systemic inflammatory response induced by cardiopulmonary bypass
    Wu, M
    Lu, YB
    Jiang, B
    Xu, SW
    Chen, RK
    Zhou, HL
    ACTA PHARMACOLOGICA SINICA, 2001, 22 (10) : 913 - 917
  • [2] The systemic inflammatory response to cardiopulmonary bypass: a narrative review
    Keunen, B.
    Van de Velde, M.
    Al Tmimi, L.
    ACTA ANAESTHESIOLOGICA BELGICA, 2020, 71 : 105 - 112
  • [3] AdipoRon Attenuates Inflammation and Impairment of Cardiac Function Associated With Cardiopulmonary Bypass-Induced Systemic Inflammatory Response Syndrome
    Jenke, Alexander
    Yazdanyar, Mariam
    Miyahara, Shunsuke
    Chekhoeva, Agunda
    Immohr, Moritz Benjamin
    Kistner, Julia
    Boeken, Udo
    Lichtenberg, Artur
    Akhyari, Payam
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (06):
  • [4] The effects of intra-operative amiodarone loading on the systemic inflammatory response syndrome induced by cardiopulmonary bypass
    Rahman, Ali
    Akbulut, Handan
    Bayar, Mustafa Kemal
    Ozden, Mehmet
    Burma, Oktay
    Uysal, Ayhan
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2009, 9 (04) : 318 - 324
  • [5] The effect of methylprednisolone treatment on the cardiopulmonary bypass-induced systemic inflammatory response
    Bourbon, A
    Vionnet, M
    Leprince, P
    Vaissier, E
    Copeland, J
    McDonagh, P
    Debré, P
    Gandjbakhch, I
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2004, 26 (05) : 932 - 938
  • [6] Effects of phospholipase D on cardiopulmonary bypass-induced neutrophil priming
    吴明
    卢韵碧
    陈如坤
    中华创伤杂志(英文版), 2004, (02) : 7 - 12
  • [7] Gene expression changes in leukocytes during cardiopulmonary bypass are dependent on circuit coating
    Seeburger, J
    Hoffmann, J
    Wendel, HP
    Ziemer, G
    Aebert, H
    CIRCULATION, 2005, 112 (09) : I224 - I228
  • [8] Cardiopulmonary bypass and the systemic inflammatory response: Effects on drug action
    Hall, RI
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2002, 16 (01) : 83 - 98
  • [9] The efficacy of parecoxib on systemic inflammatory response associated with cardiopulmonary bypass during cardiac surgery
    Wu, Qingping
    Purusram, Gunsham
    Wang, Huiqing
    Yuan, Ruixia
    Xie, Wanli
    Gui, Ping
    Dong, Nianguo
    Yao, Shanglong
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 75 (03) : 769 - 778
  • [10] Whole blood transcriptomics reveals granulocyte colony-stimulating factor as a mediator of cardiopulmonary bypass-induced systemic inflammatory response syndrome
    Martin, Katherine R.
    Gamell, Cristina
    Tai, Tsin Yee
    Bonelli, Roberto
    Hansen, Jacinta
    Tatoulis, James
    Alhamdoosh, Monther
    Wilson, Nicholas
    Wicks, Ian
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2024, 13 (02)